HRT Financial’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

HRT Financial’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,782	Closed	-$2K	–	3346
2024 Q1	$2K	Buy	15,782 +907	+6%	+$179	﹤0.01%	2161
2023 Q4	$2K	Sell	14,875 -177,699	-92%	-$27.6K	﹤0.01%	2185
2023 Q3	$33K	Buy	+192,574	New	+$239K	﹤0.01%	2033
2022 Q1	–	Sell	-21,164	Closed	-$97K	–	4056
2021 Q4	$97K	Buy	21,164 +6,462	+44%	+$21.4K	﹤0.01%	2769
2021 Q3	$119K	Sell	14,702 -9,692	-40%	-$83.1K	﹤0.01%	2849
2021 Q2	$239K	Buy	+24,394	New	+$198K	﹤0.01%	2290

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial's GRTX Position: Q2 2024 in Review

HRT Financial sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 15,782 shares — an estimated $2K sold.

HRT Financial first reported a position in GRTX in Q2 2021 and held it in 6 quarters. The position peaked at $239K in Q2 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

HRT Financial reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
HRT Financial sold 15,782 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $2K.
HRT Financial first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
HRT Financial's Galera Therapeutics, Inc. Common Stock position peaked at $239K in Q2 2021.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.